American Association of Clinical Endocrinologists (2001)
• Perimenopausal or postmenopausal women who have risk factors for fractures and are willing to consider available interventions.
• Women who have X-ray findings that suggest osteoporosis.
• Women beginning or receiving long-term glucocorticoid therapy or other drugs associated with bone loss.
• All adult women with symptomatic hyperparathyroidism or other diseases or nutritional conditions associated with bone loss in whom evidence of bone loss would result in adjustment of management.
• In women receiving treatment for osteoporosis (baseline measurements should be made before intervention.)
• In all women 40 years or older who have sustained a fracture.
• In all women beyond 65 years of age.